Press Release May 18 2026

Strides Pharma Science Limited has informed the Exchange regarding a press release dated May 18, 2026, titled "Strides Delivers Strong Performance with FY26 EBITDA at ₹9,253m, Operational PAT at ₹5,181m, 50% YoY Growth".

View Attachment